Trusted Resources: Education
Scientific literature and patient education texts
Prenatal Diagnosis of Mucopolysaccharidoses Type II by Two-Dimensional Electrophoresis and Mass Spectrometry in Amniotic Fluid
source: The journal of obstetrics and gynaecology research
year: 2022
authors: Aboulnasr AA,Elnouri A,Abdel Sameea G,Gouda AS,Ibrahim MM,Shalabi TA,Gaber KR
summary/abstract:To introduce a quantitative determination of heparan sulfate and dermatan sulfate by mass spectrometry and to compare it with two-dimensional electrophoresis of the glycosaminoglycans in the amniotic fluid for the prenatal diagnosis of mucopolysaccharidoses type II (MPS II).
organization: Prenatal Diagnosis and Fetal Medicine Department, National Research Centre, Giza, Egypt.DOI: 10.1111/jog.15135
read more
BookmarkRelated Content
-
Golgi Requires a New Casting in the Screenplay of Mucopolysaccharidosis II CytopathologyLysosome (L), a hydrolytic compartment o...
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Expanding the Phenotype of Mucopolysaccharidosis Type II RetinopathyPurpose: To report novel retinal finding...
-
Joseph Muenzer, MD, PhDJoseph Muenzer, MD, PhD is a Professor i...
-
Full Letter From Takeda to the National MPS SocietyOn behalf of Takeda, we are writing to s...
-
A Guide to Understanding MPS IIMPS II is a mucopolysaccharide disease k...
-
Hunter Syndrome (MPS II): An Uncommon Combination of Childhood Complaintshttps://www.youtube.com/watch?v=7kBGEYAF...
Powered by
